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A characterisation of the medical device development landscape in South Africa would be beneficial for 
future policy developments that encourage locally developed devices to address local healthcare needs. 
The landscape was explored through a bibliometric analysis (2000–2013) of relevant scientific papers 
using co-authorship as an indicator of collaboration. Collaborating institutions thus found were divided 
into four sectors: academia (A); healthcare (H); industry (I); and science and support (S). A  collaboration 
network was drawn to show the links between the institutions and analysed using network analysis metrics. 
Centrality measures identified seven dominant local institutions from three sectors. Group densities 
were used to quantify the extent of collaboration: the A sector collaborated the most extensively both 
within and between sectors; local collaborations were more prevalent than international collaborations. 
Translational collaborations (AHI, HIS or AHIS) are considered to be pivotal in fostering medical device 
innovation that is both relevant and likely to be commercialised. Few such collaborations were found, 
suggesting room for increased collaboration of these types in South Africa. 
Significance:
• Results could inform the development of strategies and policies to promote certain types of medical 
device development. 
• Further studies could identify drivers and barriers to successful medical device development in South Africa.
Introduction
Medical device innovation requires contributions from multiple disciplines, as well as collaboration and knowledge 
transfer across sectors. The three main sectors identified as playing a role in medical device development are 
academia (in the form of higher education institutions), healthcare and industry.1-3
The knowledge base, resources and roles vary considerably across these sectors. Academic institutions often 
possess specialised instrumentation and equipment; are responsible for local education and training at all tertiary 
levels; and add to the stock of codified knowledge through publications, patents, and software and hardware 
prototypes.4 The healthcare sector best understands the patients’ needs; and has access to currently available 
medical devices and knowledge about their shortcomings within the local context. Industry has knowledge of, and 
access to, current technologies used in the manufacture and development of medical devices; and is responsible 
for making the devices accessible to the general public.
Collaboration between organisations from the different sectors is a key component of innovation in the medical 
field.5 The benefits of academia–healthcare collaborations include increased awareness of technologies used in 
clinical practice and clinical input into research projects. Industry–academia collaboration increases the problem-
solving capacity of industry by enabling access to university equipment and specialised knowledge.4 Universities 
benefit from this collaboration through awareness of current technologies used in industry6 and access to new 
funding opportunities7.
Of particular interest for medical device innovation are so-called translational collaborations – defined here as 
collaborations between all three sectors (academia, healthcare and industry) considered essential to the biomedical 
innovation system1,8 – which enable biomedical discoveries to translate into clinical practice.2 Translation is possible 
as a result of the different, yet complementary, perspectives and social capital5 provided by each collaborator.
Collaborations between organisations can be visualised using network graphics. Such networks have been 
developed using co-authorship of scientific publications as a proxy for collaboration between individual researchers, 
their affiliated institutions and the countries in which they are based.3,9-15 These networks provide a way to ascertain 
the extent and nature of collaboration between different categories of organisation.
The main aim of this paper was to characterise the broad medical device development landscape, particularly 
with regard to collaboration, in South Africa. This characterisation was accomplished using a bibliometric network 
analysis of scientific publications to generate a collaboration network. The network was then used to: identify the 
institutions active in the field and to which sectors they belong; determine the dominant institutions (and sectors); 
quantify the extent of intra- and cross-sector collaboration; investigate the presence of foreign influence; and 
explore the prevalence of various collaboration types, with a particular focus on translational collaborations.
Co-authorship as a proxy for scientific collaboration
Scientific collaboration is a fundamental aspect of research activity, which generates knowledge flows between 
different groups of partners.16 It is driven by globalisation and the emergence of new communication technologies, 
which make it possible for different institutions to work together.17,18 Through collaboration, institutions complement 
their expertise, share available resources and create social networks, which often result in the integration of 
knowledge, efforts and capabilities as well as enhancement of productivity.19 Scientific collaboration can be 
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measured by co-authorship – which is one of the most tangible and 
well-documented forms of partnership.20,21 As scientific collaboration 
evolves, the focus is shifting from authors to the different institutions 
involved, with a trend, since the 1960s, towards interdisciplinarity.22
In analysing scientific collaboration networks, centrality measures 
(which include degree, betweenness and closeness centrality)23, can 
be used to identify dominant institutions which have greater influence 
within the network. Each centrality measure uses a different definition 
of the ‘centre’ of action in the network, although all of them analyse 
patterns of relations in the network.24 Degree centrality uses the number 
of direct contacts of an actor as an indicator of the quality of their 
interconnectedness.25,26 Usually institutions or nodes with a higher 
degree are more central to the structure and tend to have a greater ability 
to influence others.25 Betweenness centrality measures the influence 
of an individual over information flow between others27; those with 
high betweenness have the potential to influence others near them in 
a network through both direct and indirect pathways.28 Thus an actor 
with high betweenness centrality can potentially influence the spread 
of information through the network, by facilitating, hindering, or even 
altering the communication between others.29 Closeness centrality gives 
a measure of how well connected an actor is by considering the shortest 
paths between them and the other actors23, thereby quantifying how 
long the information takes to spread from a given actor to others in the 
network. As such, the extent of the influence of the actor over the entire 
network can be investigated.30,31
Lander3 suggests that, for biomedical research and development, aca-
demia is the key network sector, followed by healthcare and govern-
ment organisations, with the industry sector playing a weaker role. This 
ranking is further supported by the findings of Chimhundu et al.32 who 
showed that universities and healthcare facilities were the dominant 
sectors in cross-sector collaboration for cardiovascular medical device 
development in South Africa. Nonetheless, collaboration between all 
three sectors is essential within the biomedical innovation system to 
facilitate the translation of resources.2,8 Globally, medical research has 
high degrees of ‘extramural domestic’ collaboration between different 
institutions in the same country.33 In African countries, collaboration 
in the medical field is characterised by the dominance of international 
institutions, with collaboration driven by foreign funding.34 The economic 
and/or political dependence of a country or geopolitical region and the 
presence of special equipment that is shared in large multinational 
projects, influences the degree of co-operation.35 In a study on 
cardiovascular device development in South Africa, foreign institutions 
were found to play a role in connecting local institutions that would 
otherwise have remained isolated.32
Method
Regulatory control of medical devices has necessitated a single 
definition that would allow for their inherent diversity. Such a definition 
was proposed by the Global Harmonization Task Force (GHTF)36, a 
consortium formed in 1992 consisting of regulatory authorities and 
representatives from the medical device industry, now known as the 
International Medical Device Regulators Forum. The GHTF definition of a 
medical device has been widely accepted and is as follows37:
A medical device is any instrument, apparatus, implement, machine, 
appliance, implant, in vitro reagent or calibrator, software, material 
or other similar or related article that does not achieve its primary 
intended action in or on the human body solely by pharmacological, 
immunological or metabolic means and that is intended for human 
beings for:
• the diagnosis, prevention, monitoring, treatment or alleviation 
of disease;
• the diagnosis, monitoring, treatment, alleviation of, or com pen­
sation for an injury;
• the investigation, replacement, modification, or support of the 
anatomy or of a physiological process;
• supporting or sustaining life;
• controlling conception;
• disinfecting medical devices; and
• providing information for medical or diagnostic purposes by 
means of in vitro examination of specimens derived from the 
human body.
Publication search methodology
Because medical devices incorporate numerous technologies, it is difficult 
to define a search based on device types. Consequently, the publication 
search was structured around the three sectors – academia, healthcare 
and industry – known to be crucial elements of biomedical innovation.1,2
A list was generated of South African institutions involved in medical 
device development (see Supplementary table 1). The list consisted of 
23 universities that were in existence in South Africa at the end of 2013, 
10 academic hospitals, and a set of companies known to be active in the 
medical device field. The list of companies comprised those registered 
as part of the MDMSA (Medical Device Manufacturers South Africa) – 
an umbrella corporation for companies in South Africa that manufacture 
medical devices; MDMSA had 15 members when the search was 
executed. The list was further expanded with select members of SAMED 
(South African Medical Device Industry Association) – an association 
overseeing medical device policies, innovation, ethical principles and 
practices within South Africa. From the list of 121 SAMED members, 
17 companies were selected according to their location (based in 
South Africa) and their engagement in product development.
Table 1 outlines the search method employed using both websites 
and search engines. This exploratory search was intended to generate 
a broad overview of the South African medical device development 
landscape that would allow key players to be identified and aspects of 
collaboration to be investigated.
Filtering the search results
Articles published between January 2000 and December 2013 were 
retained. Individual publications were manually scrutinised to determine 
whether their content was related to medical device development, and 
either accepted or rejected according to the following criteria: publication 
type, affiliation and indicators of medical device development.
Publication type
Journal or conference proceeding publications were retained, as were 
articles published on the Research Space (https://researchspace.csir.
co.za/dspace/) of the Council for Scientific and Industrial Research 
(CSIR). The CSIR is a government commissioned science council 
that provides an online archive of all their research; such outputs were 
considered to be of similar credibility to publications in conference 
proceedings. Other research-related documentation (e.g. magazine 
articles, internal reports) was excluded.
Affiliation
At least one co-author was required to be affiliated with a South African 
institution.
Indicators of medical device development
Publications were required to explicitly mention a medical device (as 
determined by the GHTF definition), and to relay information that would 
aid the (further) development of said device.
Publications that discussed the use of medical devices to examine 
medical conditions, and did not aid the development of the device, were 
excluded. Typically such publications mentioned the device only in the 
methods section. Review papers were excluded as they do not contribute 
directly to device development. Animal studies that did not contribute to 
device development intended for human use, were excluded. 
Publications that presented non-medical technological advances without 
making a direct link to healthcare and a prospective medical device were 
excluded. However, if the focus of the publication was on the non-medical 
technology and a medical device was discussed as an application, then 
the publication was included. The publication of Booysen et al.38 serves 
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as an example: advancements in rapid prototyping technology are 
discussed with reference to a secure airway clamp case study. 
Device development was also understood to mean novel applications 
of existing devices. For example, Saleh et al.39 proposed using MRI 
to diagnose ventricular wall remodelling, while Bosanquet and John40 
discussed a method to extract patterns in EEG recordings during exercise-
fatigue experiments. Although MRI and EEG devices are not new, the 
applications presented were; in addition, when considering the GHTF 
definition37, both papers presented the development of ‘software intended 
for the investigation of a physiological process’. 
Only synthetic implants, grafts and/or replacements were considered to 
be acceptable. Biological samples (for instance vein grafts used in heart 
bypass surgery) were excluded. 
Extracting collaboration data
A list was extracted of the institutions with which co-authors were 
affiliated. Four sectors were identified:
1. Academia (A): higher education institutions involved in academic 
research for the development of medical devices; predominantly 
consisting of universities, polytechnics and colleges.
2. Healthcare (H): clinics, hospitals and medical facilities whose 
primary function is patient care; essential for identifying 
healthcare needs.
3. Industry (I): companies, firms, organisations and individuals involved 
in medical device development for purposes of com mercialisation.
4. Science and support (S): any organisation, not belonging to one of 
the other sectors, that contributes to, or utilises, the scientific body of 
knowledge through research, education and training, clinical services 
and/or community services. This includes science councils, other 
research facilities, non-government organisations (NGOs), non-
profit organisations (NPOs) and designated special interest groups.
Science councils and facilities concentrate on performing social, scientific 
and technological research in accordance with their commission by the 
South African government under the Scientific Research Council Act 
46 of 1988. NGOs and NPOs may serve as a source of research and 
information and offer assistance and educational opportunities. Special 
interest groups are recognised as such by the South African Medical 
Association, and promote the practice and study of a particular field 
of medicine.
The institutions were further assessed by applying the following filters:
• Departmental affiliations were omitted and only the affiliation 
with the parent institution was retained. An exception to this rule 
was in the case of academic hospitals. For instance an author 
affiliated with Onderstepoort Veterinary Academic Hospital 
(OVAH), which is associated with the University of Pretoria 
(UP), was recorded as having a H sector affiliation. If the author 
was jointly affiliated with a UP department, a second A sector 
affiliation was recorded.
• Private hospitals belonging to a larger conglomerate (e.g. 
MediClinic, Life Health and Netcare) were still considered as 
individual hospitals. This was thought to better reflect collaboration 
at the institutional level.
• Branches of large multinationals in different locations were 
considered separately, e.g. Siemens Healthcare (Atlanta, GA, 
USA), versus Siemens Medical Solutions (Baltimore, MD, USA).
After filtering, the country in which each institution was based was 
recorded.
Collaboration network generation and analysis
A collaboration network was generated and analysed using UCINET 
(version 6.474)41 and NetDraw (version 2.131)42. Within such networks, 
each institution is represented by a network node, while edges (ties 
between nodes) represent publications on which the institutions 
collaborated. Edge thickness was weighted according to the number of 
collaborative publications; edges were undirected, as collaboration is a 
reciprocal relationship.
NetDraw’s spring-embedding graph layout algorithm was used to 
draw the network, followed by manual manipulation of node positions 
as necessary to ensure labels were legible. The size, shape and 
colour of the nodes were used to highlight features of interest, namely 
Table 1:  Search methodology for finding medical devices developed in South Africa (2000–2013)
Universities
1. The existence of a Faculty of Engineering and/or a Faculty of Health Sciences or Medical School was determined for each of the 23 universitiesa from their websites. 
2. Provided either, or both, of these faculties existed, the presence of a biomedical engineering department or grouping within the faculties was determined.
3. Any biomedical engineering department websites, thus found, were searched for publication lists typically provided as evidence of departmental or staff research 
activities.
4. PubMedb was used to search for university publications using the following key words and filters:
Search phrase: ‘medical devices South Africa’
Publication date: selected to be from 1 January 2000 to 31 December 2013
Species: only medical devices developed for human application were considered
Language: only papers written in English were assessed
Text availability: only papers for which we had full-text access were considered so as to ensure accurate classification of the paper as being on medical device 
development, based on its full content
Hospitals
1. The 10 hospitala websites were searched for listings of research activities.
2. The hospital names were used as search terms in Google Scholar and PubMed, using the same search criteria as in the university search. In the case of 
hospitals that are known under multiple names, all names were used as search terms.
Companies
1. The 32 companya websites were searched for listings of company and staff research activities.
2. Staff research activities were further investigated through Google searches of relevant staff members.
3. If steps (1) and (2) yielded no publications, an additional Google Scholar search was performed for either the company name or an abbreviation thereof.
aIndividual institutions are listed in Supplementary table 1. 
bPubMed was developed by the US National Centre for Biotechnology Information at the US National Institute of Health; it contains biomedical literature from over 25 000 journals 
and includes MEDLINE.
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connectedness to other institutions, sector classification and institutional 
location, respectively.
Structural analysis
The following centrality measures24,43 were used to identify the central 
nodes (i.e. dominant institutions):
• Degree: The number of connections or edges that a node has to 
other nodes.
• Betweenness: The number of times a node falls on the geodesic 
distance between all pairs of nodes in the network, normalised with 
respect to the maximum possible betweenness a node could have.
• Closeness: Calculated for a node (Nn) by dividing the number 
of remaining nodes in the network (n−1) by the sum of all 
distances between node Nn and each of the remaining nodes. 
Closeness values were calculated for the largest component within 
the network.27
The centrality measures were normalised using the number of nodes 
present in the network.44-46
Collaboration analysis
Network density measures the speed of information diffusion among 
nodes24 and is defined as the sum of edges present in a network 
between groups of nodes, divided by the maximum number of edges that 
could possibly exist between the nodes. When calculated for different 
groups within a network, density provides insight into the exchange of 
information within and between the groups. In this paper, group densities 
are used to evaluate the extent of collaboration at both the sectoral and 
international levels.
Additionally, the various types of sectoral collaboration and their 
prevalence within the network were considered. For instance, if a 
publication has two co-authors, one affiliated with a university (sector A) 
and the other with a company (sector I), the publication represents an AI 
type of cross-sectoral collaboration. Translational collaborations include 
three possible groupings of the four sectors: AHI, HIS and AHIS. Each 
sector contributes different, yet complementary, resources. Typically, 
the A sector provides a research/development component, the H sector 
may be responsible for identifying the patient needs to be addressed, 
and the I sector may be responsible for getting the product to market. 
Recalling that in this study, the S sector has similar resources to those 
of the A sector, translational collaborations are consequently considered 
to comprise the A and/or the S sector, in combination with the H and 
I sectors.
Limitations of the data set
The data set presented in this paper has three inherent shortcomings. 
First, even though bibliometric studies often make use of co-authorship 
as an indicator of collaboration, co-authorship can at best only be 
considered a partial indicator as not all collaborations are formally 
acknowledged through a co-authorship.47 This is especially true at the 
micro-level, when considering individual collaborators; however, the 
problem is lessened when considering collaborations at the macro-
level (i.e. the institutional level). Second, because of the exploratory 
nature of the publication search, not all relevant publications would 
have been found. However, by the very nature of medical devices, 
conducting an exhaustive search would not be practicable. Third, the 
type of publications considered (namely journal articles and conference 
proceedings) are the preferred output for the A sector. The other three 
sectors would not necessarily use these forums to document their 
medical device development activities. As such the data set may be 
biased towards activity within the A sector.
The data set was considered suitable for an initial investigation into 
collaboration activities and the parties involved.
Results and discussion
After filtering the search results, a total of 171 publications remained, 
comprising 781 authors affiliated with 116 institutions from the four 
sectors (45 A; 36 H; 21 I; 14 S).
Collaboration network
Figure 1 shows the collaboration network for institutions (nodes) found to 
be active in medical device development during the period 2000–2013. 
Both local (South African) and foreign (international) institutions are 
shown; node colour is used to differentiate between the two locations. 
Furthermore, node shape is used to represent the sector to which each 
institution belongs (A, diamond; H, circle; I, square; S, triangle), while 
node size is scaled according to the node degree. Abbreviations used for 
the institution names are listed in Supplementary tables 2–5.
The collaboration network provides a first step in characterising the 
medical device development landscape in South Africa. Of the 116 
institutions, 56 are local and 60 are foreign. These institutions can be 
further broken down to the sectoral level: A(11 local, 34 foreign); H(24 
local, 12 foreign); I(10 local, 11 foreign); and S(11 local, 3 foreign).
Comparing the proportion of institutions (both local and foreign) 
within each sector (A-39%; H-31%; I-18%; S-12%) against those 
found by Lander3 for the infection and immunity network in Canada 
(university-37%; hospital-23%; government-18%; firm-14%; NGO-8%) 
echoes the dominance of the academia sector. However, more 
healthcare institutions were present in the South African landscape, 
while the industry sector proportions are similar. The government and 
NGO sectors identified by Lander3 are similar in nature to the institutions 
belonging to the S sector of this study. More institutions from these 
sectors were present in the network in Canada than in South Africa.
In the academia sector, nearly half (11/23) of the South African 
universities were found to be active in medical device development. 
These local institutions, however, were far outnumbered by the foreign 
institutions. Foreign universities therefore make a substantial intellectual 
contribution to medical device development activity in South Africa, 
although their role cannot be determined from the current analysis. 
However, the network does show that the foreign nodes have low degree, 
which would imply low influence for the individual nodes.
Far more local than foreign healthcare institutions are present in 
the network. Such local collaborations are critical if medical device 
development is to target local healthcare needs; however, further 
analysis would be required to ascertain if there is alignment between the 
types of devices being developed and the healthcare needs.
Dominant institutions
The dominant institutions within the network were identified by calculating 
three centrality measures (degree, closeness and betweenness) and 
listing the 10 highest ranking nodes for each measure (Table 2). These 
measures indicate different ways in which institutions exhibit dominance 
in the network. Nodes with high degree have a greater ability to influence 
others, while high betweenness measures the institution’s ability to spread 
information through the network, and closeness indicates which nodes 
could potentially facilitate the efficient spread of knowledge in the network.
According to Goh et al.48, a network typically constitutes a small number 
of influential individuals and many peripheral actors. The findings in 
Table 2 agree with this observation. Seven local nodes are common 
to all three centrality measures: UCT (University of Cape Town), GSH 
(Groote Schuur Hospital), SUN (Stellenbosch University), UP (University 
of Pretoria), WITS (University of the Witwatersrand), TH (Tygerberg 
Hospital) and NHLS (National Health Laboratory Services). The order 
in which these institutes appear varies for each measure, although UCT 
is consistently the highest ranked node, while GSH and SUN share the 
second and third highest rankings. Four of the seven institutions are 
from the A sector, two from the H sector and one from the S sector. It 
should also be noted that both of the H sector institutions are academic 
hospitals. This dominance exhibited by the A and H sectors is consistent 
with the findings of Lander3.
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Table 2: Ten highest ranking nodes for the normalised centrality measures: degree, closeness and betweenness
Rank
Degree centrality Closenessa centrality Betweenness centrality
Institution Sector Value Institution Sector Value Institution Sector Value
1 UCT A 0.461 UCT A 0.642 UCT A 0.432
2 GSH H 0.348 GSH H 0.552 SUN A 0.247
3 SUN A 0.278 SUN A 0.538 GSH H 0.235
4 UP A 0.165 NHLS S 0.502 UP A 0.182
5 WITS A 0.157 WITS A 0.495 WITS A 0.088
6 HU* A 0.096 TH H 0.473 UL A 0.047
7 TH H 0.096 UP A 0.469 NHLS S 0.041
8 NHLS S 0.078 UWC A 0.461 KEH H 0.032
9
Six institutionsb 0.070
UVA* A 0.459 CSIR S 0.027
10 UFS A 0.455 TH H 0.022
A, academia; H, healthcare; I, industry; S, science and support; *foreign institutions.
Institution names and abbreviations are listed in Supplementary tables 2–5.
aCloseness calculated for the largest component comprising 107 of the total 116 institutions.
bThe six institutions with equal degree were: BWH*(H); DINC*(I); UTUB*(A); DTI*(I); UA*(A); PIH*(S).
Figure 1: Collaboration network of institutions generated using all relevant publications found during the period 2000–2013. Node size scaled according 
to node degree. Edge thickness weighted according to number of publications co-authored. Institution names and abbreviations are listed in 
Supplementary tables 2–5. 
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Universities are seen to form hubs that facilitate the exchange of 
information within the network; they are typically well connected and 
are considered to be influential in the development of medical devices. 
Because of their position in the network, universities have the potential to 
help establish new collaborations with other institutions in the network.
The industry sector is absent from Table 2, except for two foreign 
organisations. This finding may be as a result of the bias inherent in 
the network, namely that journal article publication is not imperative 
for industry. However, it could also indicate that local industry is not a 
dominant figure in medical device innovation within South Africa. Further 
investigation, possibly through patent analysis, could produce more 
insight. Another possible explanation of the low industry presence in 
the South African co-publication landscape could be that the academic 
research being generated is not finding a market. Lander and Atkinson-
Grosjean2 described a number of translational pathways necessary 
for biomedical innovation, one of which was the commercial pathway 
which characterised movement between academia and the marketplace, 
typically facilitated by the I sector. Further analysis would be needed to 
investigate the extent of this pathway in South Africa.
Sectoral and international collaboration
Extent of collaboration
Table 3 shows the group densities (ρ) that were calculated for the four 
sectors. Within-group densities lie on the diagonal of the table, are shown 
in bold, and represent intra-sectoral collaboration. The remaining entries in 
the table are the between-group densities, which represent cross-sectoral 
collaboration. The table is symmetric, because of the reciprocal nature 
of collaboration in the network. The sum of edge weights (∑ew) used to 
calculate the densities is also shown in the table; these values indicate the 
number of edges present in the network, taking into account the weight of 
the edges, which connect all the nodes belonging to the various sectors. 
For instance, the summed weight of all edges in the network that connect 
institutions from the A sector to those of the H sector is 114.
Considering only intra-sectoral collaboration, from highest density 
to lowest we can rank the sectors as follows: A, H, S, I. The fact that 
universities are seen to collaborate extensively with one another (the 
density of 0.088 seen for AA collaboration is the highest in the entire 
table), is to be expected. Low intra-sector collaboration within the I 
sector (ρ=0.014; one of the lowest values in the entire table) is evident, 
perhaps because local companies perceive little commercial gain in II 
collaboration. The relatively high density seen for the H sector (ρ=0.065) 
could stem from the fact that many of the hospitals in the network are 
academic hospitals and may reflect university research practices.
With regard to cross-sectoral collaboration, the three highest ranking colla-
boration types are AH (ρ=0.070; ∑ew=114), AS (ρ=0.063; ∑ew=40) 
and AI (ρ=0.049; ∑ew=46), while the two lowest ranking collaboration 
types are IS (ρ=0.014; ∑ew=4) and HS (ρ=0.012; ∑ew=6).
AH has the highest cross-sectoral collaboration density – a finding in 
agreement with that of Chimhundu et al.32 for cardiovascular devices. 
The next highest cross-sector density was found for AS collaborations, 
even though the S sector (14 institutions) is considerably smaller than 
the H sector (36 institutions). When comparing AS and AI, even though 
AS has the higher ρ value, the ∑ew value is lower than that of AI. This 
result is explained by the fact that there are fewer S sector (14) than I 
sector (21) institutions. What these observations indicate, is that small 
sectors like the S sector can still be extensively involved in collaboration 
activities, and conversely, that larger sectors do not necessarily engage 
in more instances of collaboration.
The A sector is seen to collaborate extensively both intra- and cross-
sectorally as it is present in the highest ranking collaboration types for both 
cases, and is seen to readily collaborate with all other sectors. Interestingly, 
the S sector is found to be present in one of the highest ranking cross-
sectoral collaboration types (AS), as well as the two lowest (IS and HS).
A similar analysis was carried out to investigate the extent of international 
collaboration, the results of which are also shown in Table 3. Local 
only (l-l) collaboration is shown in bold text, while local-foreign (l-f) 
collaboration is shown in normal text. The number of local institutions in 
the network is about the same as the number of foreign institutions (56 
and 60 respectively). Nonetheless the l-l density is almost three times 
greater than that of the l-f collaborations. Even though foreign institutions 
do have a presence in the South African medical device development 
landscape, local institutions collaborate far more extensively with one 
another than with foreign institutions.
Collaboration type prevalence
Publications were sorted according to the type of sectoral collaboration 
each represented. The number of publications thus found was further 
divided to show collaborations that involved only local institutions; 
mixed collaborations with more than one local institution and additional 
foreign involvement; and, foreign collaborations (a single local institution 
collaborating with foreign institutions). The proportions of the local, 
mixed and foreign collaborations are indicated in Figure 2.
A, academia; H, healthcare; I, industry; S, science and support.
Figure 2: Number of publications during the period 2000–2013 classified 
according to sectoral collaboration.
Table 3: Quantitative measures of within-group (bold text; intra-sectoral or local) and between-group (normal text; cross-sectoral or international) 
collaboration
A H I S Local
ρ ∑ew ρ ∑ew ρ ∑ew ρ ∑ew ρ ∑ew
A 0.088 174 0.070 114 0.049 46 0.063 40 Local 0.116 356
H 0.070 114 0.065 82 0.032 24 0.012 6 Foreign 0.041 138
I 0.049 46 0.032 24 0.014 6 0.014 4
S 0.063 40 0.012 6 0.014 4 0.044 8
ρ, density; ∑ew, sum of edge weights; A, academia; H, healthcare; I, industry; S, science and support.
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Even though the number of foreign institutions (60) present in the 
network is slightly greater than the number of local institutions (56), 
123 of the total 171 publications (72%) were found to represent local 
collaboration. This proportion far exceeded the 20 publications (12%) 
representing mixed collaboration and 28 publications (16%) showing 
foreign collaboration. Thus local institutions collaborate far more locally 
than internationally. This observation is in agreement with the findings 
of Sooryamoorthy49 who investigated partnership trends evident in 
South African medical research (1975–2005). Sooryamoorthy49 showed 
that out of 5642 medical research publications, only 20.6% involved 
international partnerships in which at least one co-author was affiliated 
with an institution from a foreign country.
In Figure 2, translational collaboration types are represented by the 
columns labelled AHI, HIS and AHIS. Of these three collaboration 
types, AHI was the most active, HIS had no publications, and AHIS 
only had mixed collaborations. The low number of publications (7%; 
12 out of 171) involving translational collaborations may be indicative 
of the biomedical innovation chain in South Africa not fully utilising the 
pathways presented by Lander and Atkinson-Grosjean2. Even though 
there is evidence of medical device development activity and cross-
sectoral collaboration occurring locally within the country, the lack 
of translational collaborations could indicate that the devices being 
developed may not be relying on evidence of healthcare needs from the 
H sector, or are not reaching the market (lack of I sector involvement). 
However, the fact that there are institutions from the various sectors 
engaging in medical device development, means that collaborative 
opportunities exist. A study by Chinchilla-Rodríguez et al.50 investigating 
medical research collaboration in Latin America and the Caribbean 
(2003–2007) showed that through the implementation of policies 
to promote desired intra-regional collaboration, the growth of select 
collaboration types can indeed be fostered.
Summary and conclusion
We examined the South African medical device development landscape 
for the period 2000–2013. Through a bibliometric analysis in which 
co-authorship on scientific papers was interpreted as an indicator 
of collaboration, a collaboration network of the medical device 
development field was produced. Four sectors – academia, healthcare, 
industry, and science and support – were identified as being active in 
device development. The dominant institutions within the network were 
identified according to their influence on other institutions, their ability 
to quickly disseminate information through the network, and their ability 
to broker the exchange of information between institutions. Of these, 
seven local institutions, from three of the four sectors (4-A, 2-H, 1-S), 
were found to be the most dominant. The three highest-ranking dominant 
institutions were the University of Cape Town (UCT), Groote Schuur 
Hospital (GSH) and Stellenbosch University (SUN).
Collaboration activities at the sectoral level were investigated. With 
regard to intra-sector collaboration, the A sector collaborated the most, 
followed by the H sector and then the S sector.
About the same number of local and foreign institutions (56 and 60, 
respectively) were present in the network. The local institutions, 
however, were seen to collaborate far more with each other (72% of all 
collaborations) than with international institutions (28%).
There were far fewer translational collaborations – involving at least 
three different sectors (A or S, H and I) – present in the South African 
medical device field, compared with intra-sectoral collaborations, or 
cross-sectoral collaborations involving two different sectors. Thus there 
is room for increased translational collaboration within South Africa, 
potentially for greater health impact. Policies structured to help engender 
more cross-sector interaction could benefit medical device development, 
by creating opportunities for more translational collaborations.
Acknowledgements
We thank Mr Mohammed Esmail (Cape Peninsula University of 
Technology), Ms Katharina Hauprich (University of Applied Sciences 
Hamm-Lippstadt) and Dr Robyn May (University of Cape Town), for their 
contributions to the collection, filtering and exploration of the data. This 
work was supported by the Community Engagement Programme of the 
South African National Research Foundation (NRF) [82624]; the South 
African Research Chairs Initiative of the Department of Science and 
Technology and the NRF [98788]; the Andrew W. Mellon Foundation; 
and the Programme for the Enhancement of Research Capacity (PERC) 
at the University of Cape Town.
Authors’ contributions
T.S.D. was the project leader and was responsible for funding acquisition. 
K.d.J., C.C. and T.S.D. were responsible for conceptualisation and 
developed the bibliometric and network analysis methodology employed. 
K.d.J. oversaw the data collection and analysis. K.d.J. and C.C. were 
responsible for data curation. T.S. developed the theoretical framework. 
K.d.J. wrote the initial draft of the manuscript. C.C., T.S. and T.S.D. 
contributed to the interpretation of results and reviewed and edited the 
manuscript.
References
1. Hicks D, Katz JS. Hospitals: The hidden research system. Sci Public Policy. 
1996;23(5):297–304. https://doi.org/10.1093/spp/23.5.297
2. Lander B, Atkinson-Grosjean J. Translational science and the hidden research 
system in universities and academic hospitals: A case study. Soc Sci Med. 
2011;72(4):537–544. https://doi.org/10.1016/j.socscimed.2010.11.019
3. Lander B. Sectoral collaboration in biomedical research and development. 
Scientometrics. 2013;94(1):343–357. https://doi.org/10.1007/s11192-012-
0776-8
4. Lester RK. Universities, innovation, and the competitiveness of local 
economies: A summary report from the Local Innovation Systems Project 
– Phase I. Working Paper 05-010 [document on the Internet]. c2005 [cited 
2016 Jul 13]. Cambridge, MA: Industrial Performance Center, Massachusetts 
Institute of Technology. Available from: http://web.mit.edu/lis/papers/LIS05-
010.pdf
5. Lander B. The role of institutions and capital in intersectoral collaboration: 
Infection and immunity research and development collaboration in Vancouver. 
Rev Policy Res. 2014;31(5):390–407. https://doi.org/10.1111/ropr.12086
6. Fries RC, Glave SA, Radick MK. The benefits of industry–university interaction. 
In: Proceedings of the 30th Annual International Conference of the IEEE 
Engineering in Medicine and Biology Society (EMBC); 2008 August 20–25; 
Vancouver, Canada. IEEE; 2008. p. 1598–1601. https://doi.org/10.1109/
IEMBS.2008.4649477
7. Douglas TS. Drivers and restrainers of relevance in graduate BME education 
– A South African study. In: Proceedings of the 34th Annual International 
Conference of the IEEE Engineering in Medicine and Biology Society (EMBC); 
2012 August 28 – September 01; San Diego, CA, USA. IEEE; 2012; p. 5054–
5057. https://doi.org/10.1109/EMBC.2012.6347129
8. The Academy of Medical Sciences FORUM. Academia, industry and the NHS: 
Collaboration and innovation – Meeting report. c2010 [cited 2014 Nov 27]. 
Available from: http://www.acmedsci.ac.uk/viewFile/publicationDownloads/
Collabor.pdf 
9. Breschi S, Catalini C. Tracing the links between science and technology: 
An exploratory analysis of scientists’ and inventors’ networks. Res Policy. 
2010;39(1):14–26. https://doi.org/10.1016/j.respol.2009.11.004
10. Meyer M, Bhattacharya S. Commonalities and differences between scholarly 
and technical collaboration. Scientometrics. 2004;61(3):443–456. https://
doi.org/10.1023/B:SCIE.0000045120.04489.80
11. Abbasi A, Altmann J. On the correlation between research performance and 
social network analysis measures applied to research collaboration networks. 
In: Proceedings of the 2011 44th Hawaii International Conference on System 
Sciences (HICSS); 2011 January 4–7; Kauai, HI, USA. IEEE; 2011. p. 1–10. 
https://doi.org/10.1109/HICSS.2011.325
12. Gazni A, Sugimoto CR, Didegah F. Mapping world scientific collaboration: 
Authors, institutions, and countries. J Am Soc Inf Sci Tec. 2012;63(2):323–
335. https://doi.org/10.1002/asi.21688
13. Ding Y. Scientific collaboration and endorsement: Network analysis of 
coauthorship and citation networks. J Informetr. 2011;5(1):187–203. https://
doi.org/10.1016/j.joi.2010.10.008
Research Article The medical device development landscape in South Africa
Page 7 of 8
8South African Journal of Science  http://www.sajs.co.za
Volume 113 | Number 5/6 
May/June 2017
14. Newman M. Scientific collaboration networks I: Network construction and 
fundamental results. Phys Rev E. 2001;64(1), Art. #016131, 8 pages. 
https://doi.org/10.1103/PhysRevE.64.016131 
15. Ramlogan R, Mina A, Tampubolon G, Metcalfe JS. Networks of knowledge: The 
distributed nature of medical innovation. Scientometrics. 2007;70(2):459–
489. https://doi.org/10.1007/s11192-007-0212-7
16. Abramo G, D’Angelo CA, Solazzi M. Are researchers that collaborate more 
at the international level top performers? An investigation on the Italian 
university system. J Informetr. 2011;5(1):204–213. https://doi.org/10.1016/j.
joi.2010.11.002
17. Hoekman J, Frenken K, Tijssen RJ. Research collaboration at a distance: 
Changing spatial patterns of scientific collaboration within Europe. Res Policy. 
2010;39(5):662–673. https://doi.org/10.1016/j.respol.2010.01.012
18. Ynalvez MA, Shrum WM. Professional networks, scientific collaboration, 
and publication productivity in resource-constrained research institutions 
in a developing country. Res Policy. 2011;40(2):204–216. https://doi.
org/10.1016/j.respol.2010.10.004
19. Powell WW, Koput KW, Smith-Doerr L. Interorganizational collaboration and 
the locus of innovation: Networks of learning in biotechnology. Admin Sci 
Quart. 1996;41(1):116–145. https://doi.org/10.2307/2393988
20. Franceschet M, Costantini A. The effect of scholar collaboration on impact 
and quality of academic papers. J Informetr. 2010;4(4):540–553. https://doi.
org/10.1016/j.joi.2010.06.003
21. Glänzel W, Schubert A. Double effort = double impact? A critical view at 
international co-authorship in chemistry. Scientometrics. 2001;50(2):199–
214. http://dx.doi.org/10.1023/A:1010561321723 
22. Qin J. An investigation of research collaboration in the sciences through the 
philosophical transactions 1901–1991. Scientometrics. 1994;29(2):219–
238. https://doi.org/10.1007/BF02017974
23. Yan E, Ding Y. Applying centrality measures to impact analysis: A coauthorship 
network analysis. J Am Soc Inf Sci Tec. 2009;60(10):2107–2118. https://doi.
org/10.1002/asi.21128
24. Hanneman RA, Riddle M. Introduction to social network methods. Riverside, 
CA: University of California; 2005.
25. Landherr A, Friedl B, Heidemann J. A critical review of centrality measures 
in social networks. Bus Inf Syst Eng. 2010;2(6):371–385. https://doi.
org/10.1007/s12599-010-0127-3
26. Valente TW, Coronges K, Lakon C, Costenbader E. How correlated are 
network centrality measures? Connect (Tor). 2008;28(1):16–26.
27. Opsahl T, Agneessens F, Skvoretz J. Node centrality in weighted networks: 
Generalizing degree and shortest paths. Soc Networks. 2010;32(3):245–
251. https://doi.org/10.1016/j.socnet.2010.03.006
28. Abbasi A, Hossain L, Leydesdorff L. Betweenness centrality as a driver of 
preferential attachment in the evolution of research collaboration networks. 
J Informetr. 2012;6(3):403–412. https://doi.org/10.1016/j.joi.2012.01.002
29. Dolev S, Elovici Y, Puzis R. Routing betweenness centrality. J Acm. 
2010;57(4):1–27. https://doi.org/10.1145/1734213.1734219
30. Okamoto K, Chen W, Li XY. Ranking of closeness centrality for large-scale 
social networks. In: Preparata FP, Wu X, Yin J, editors. Frontiers in algorithmics. 
Lecture notes in computer science volume 5059. Berlin: Springer; 2008. p. 
186–195. https://doi.org/10.1007/978-3-540-69311-6
31. Wehmuth K, Ziviani A. DACCER: Distributed Assessment of the Closeness 
CEntrality Ranking in complex networks. Comput Netw. 2013;57(13):2536–
2548. https://doi.org/10.1016/j.comnet.2013.05.001
32. Chimhundu C, De Jager K, Douglas T. Sectoral collaboration networks for 
cardiovascular medical device development in South Africa. Scientometrics. 
2015;105(3):1721–1741. https://doi.org/10.1007/s11192-015-1743-y
33. Thijs B, Glänzel W. A structural analysis of collaboration between 
European research institutes. Res Evaluat. 2010;19(1):55–65. https://doi.
org/10.3152/095820210X492486
34. Pouris A, Ho YS. Research emphasis and collaboration in Africa. 
Scientometrics. 2013;98(3):2169–2184. https://doi.org/10.1007/s11192-
013-1156-8
35. Glänzel W, Schubert A. Analysing scientific networks through co-authorship. 
In: Moed HF, Glänzel W, Schmoch U, editors, Handbook of quantitative 
science and technology research. Dordrecht: Springer Netherlands; 2005. p. 
257–276. https://doi.org/10.1007/1-4020-2755-9_12
36. Global Harmonization Task Force Study Group 1. Information document 
concerning the definition of the term “medical device”. c2005 [cited 2014 
Jul 07]. Available from: http://www.imdrf.org/docs/ghtf/final/sg1/technical-
docs/ghtf-sg1-n29r16-2005-definition-medical-device-050520.pdf
37. World Health Organization (WHO). Medical devices: Managing the mismatch: An 
outcome of the priority medical devices project. Geneva: WHO; 2010. Available 
from: http://apps.who.int/iris/ bitstream/10665/44407/1/9789241564045_
eng.pdf
38. Booysen G, De Beer D, Truscott M, Combrinck J, Mosimanyane D. Combining 
additive fabrication and conventional machining technologies to develop a 
hybrid tooling approach. In: Proceedings of the 21st International DAAAM 
Symposium volume 21. Vienna: DAAAM International; 2010. p. 1563–1564. 
Available from: http://www.daaam.info/Downloads/Pdfs/proceedings/
proceedings_2010/24988_Annals_1_head.pdf
39. Saleh MG, Sharp SK, Alhamud A, Spottiswoode BS, Van der Kouwe AJW, 
Davies NH, et al. Long-term left ventricular remodelling in rat model of 
nonreperfused myocardial infarction: Sequential MR imaging using a 3T 
clinical scanner. J Biomed Biotechnol. 2012;2012, Art. #504037, 10 pages. 
https://doi.org/10.1155/2012/504037
40. Bosanquet D, John L. A method for investigating alpha band phase 
synchronization in the cortex during a fatiguing muscle contraction using 
EEG. In: The 2006 International Conference on Scientific Computing 
(CSC). USA. 2006. Available from: https://www.semanticscholar.org/
paper/A-Method-For-Investigating-Alpha-Band-Phase-Bosanquet-John/
b6b6a00a836a21f6af7c3480d5ed6c3f57934d0a
41. Borgatti SP, Everett MG, Freeman LC. Ucinet for Windows: Software for social 
network analysis. Harvard, MA: Analytic Technologies; 2002. Available from: 
https://sites.google.com/site/ ucinetsoftware/home
42. Borgatti SP. NetDraw software for network visualization. Lexington, KY: 
Analytic Technologies; 2002. Available from: https://sites.google.com/site/
netdrawsoftware/home
43. De Prato G, Nepelski D. Global technological collaboration network: Network 
analysis of international co-inventions. J Technol Transf. 2014;39(3):358–
375. https://doi.org/10.1007/s10961-012-9285-4
44. Abbasi A, Altmann J, Hossain L. Identifying the effects of co-authorship 
networks on the performance of scholars: A correlation and regression 
analysis of performance measures and social network analysis measures. 
J Informetr. 2011;5(4):594–607. https://doi.org/10.1016/j.joi.2011.05.007
45. Cimenler O, Reeves KA, Skvoretz J. A regression analysis of researchers’ 
social network metrics on their citation performance in a college of 
engineering. J Informetr. 2014;8(3):667–682. https://doi.org/10.1016/j.
joi.2014.06.004
46. Rodriguez Miramontes J, Gonzalez-Brambila CN. The effects of external 
collaboration on research output in engineering. Scientometrics. 
2016;109(2):661–675. https://doi.org/10.1007/s11192-016-2054-7
47. Laudel G. What do we measure by co-authorships? Res Evaluat. 
2002;11(1):3–15. https://doi.org/10.3152/147154402781776961
48. Goh KI, Oh E, Jeong H, Kahng B, Kim D. Classification of scale-free 
networks. Proc Natl Acad Sci USA. 2002;99(20):12583–12588. https://doi.
org/10.1073/pnas.202301299
49. Sooryamoorthy R. Medical research in South Africa: A scientometric 
analysis of trends, patterns, productivity and partnership. Scientometrics. 
2010;84(3):863–885. https://doi.org/10.1007/s11192-010-0169-9
50. Chinchilla-Rodríguez Z, Benavent-Pérez M, De Moya-Anegón F, Miguel S. 
International collaboration in medical research in Latin America and the 
Caribbean (2003–2007). J Am Soc Inf Sci Tec. 2012;63(11):2223–2238. 
https://doi.org/10.1002/asi.22669
Research Article The medical device development landscape in South Africa
Page 8 of 8
